Skip to main content
Journal cover image

Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival

Publication ,  Conference
Cuneo, KC; Vredenburgh, JJ; Sampson, JH; Reardon, DA; Desjardins, A; Willett, CG; Kirkpatrick, JP
Published in: International Journal of Radiation Oncology*Biology*Physics
November 2009

Duke Scholars

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

November 2009

Volume

75

Issue

3

Start / End Page

S249 / S250

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cuneo, K. C., Vredenburgh, J. J., Sampson, J. H., Reardon, D. A., Desjardins, A., Willett, C. G., & Kirkpatrick, J. P. (2009). Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival. In International Journal of Radiation Oncology*Biology*Physics (Vol. 75, pp. S249–S250). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2009.07.576
Cuneo, K. C., J. J. Vredenburgh, J. H. Sampson, D. A. Reardon, A. Desjardins, C. G. Willett, and J. P. Kirkpatrick. “Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival.” In International Journal of Radiation Oncology*Biology*Physics, 75:S249–50. Elsevier BV, 2009. https://doi.org/10.1016/j.ijrobp.2009.07.576.
Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Willett CG, et al. Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2009. p. S249–50.
Cuneo, K. C., et al. “Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival.” International Journal of Radiation Oncology*Biology*Physics, vol. 75, no. 3, Elsevier BV, 2009, pp. S249–50. Crossref, doi:10.1016/j.ijrobp.2009.07.576.
Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Willett CG, Kirkpatrick JP. Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2009. p. S249–S250.
Journal cover image

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

November 2009

Volume

75

Issue

3

Start / End Page

S249 / S250

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences